Monday, December 19, 2016

BRIEF-Conatus to receive $50 mln in liver drug deal with Novartis

* Conatus Pharmaceuticals Inc says full funding in position

for remaining development of Emricasan

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)